AMOXICILLIN DIN 02237154
Health Canada record
| Active ingredient(s) | AMOXICILLIN 500 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01CA04 AMOXICILLIN |
| Original market date | |
| Current status date | 27-Apr-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
BGP Pharma ULC — licence 102234, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AMOXICILLIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00795925 | AMOXICILLIN TAB 100MG | P.V.U., DIVISION OF VÉTOQUINOL N.-A. INC. | Tablet | AMOXICILLIN 100 MG | Cancelled Post Market |
| 00288500 | AMOXIL 125 ORAL SUSPENSION | AYERST LABORATORIES | Suspension | AMOXICILLIN 25 MG | Cancelled Post Market |
| 00288497 | AMOXIL 250 CAP | AYERST LABORATORIES | Capsule | AMOXICILLIN 250 MG | Cancelled Post Market |
| 00288519 | AMOXIL 250 ORAL SUSPENSION | AYERST LABORATORIES | Suspension | AMOXICILLIN 50 MG | Cancelled Post Market |
| 00330531 | AMOXIL CAP 500MG | AYERST LABORATORIES | Capsule | AMOXICILLIN 500 MG | Cancelled Post Market |
| 02041685 | AMOXIL CHEWABLE TABLETS 125MG | WYETH-AYERST CANADA INC. | Tablet | AMOXICILLIN 125 MG | Cancelled Post Market |
| 00574929 | MOXILEAN 50 SUS 50MG/ML | MTC PHARMACEUTICALS | Powder For Solution | AMOXICILLIN 750 MG | Dormant |
| 00865567 | NU-AMOXI CAP 250MG | NU-PHARM INC | Capsule | AMOXICILLIN 250 MG | Cancelled Post Market |
| 00865575 | NU-AMOXI CAP 500MG | NU-PHARM INC | Capsule | AMOXICILLIN 500 MG | Cancelled Post Market |
| 02240829 | RIVA-AMOXICILLIN 125MG/5ML FOR ORAL SUSPENSION | LABORATOIRE RIVA INC. | Powder For Solution | AMOXICILLIN 125 MG | Cancelled Post Market |
| 02240830 | RIVA-AMOXICILLIN 250MG/5ML FOR ORAL SUSPENSION | LABORATOIRE RIVA INC. | Powder For Solution | AMOXICILLIN 250 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 16621 | 2015-02-19 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER |
| 2702 | 1998-01-22 | New Drug Submission (NDS) |
International API supply for AMOXICILLIN
17 active FDA Drug Master Files.
Request a quote for AMOXICILLIN